In the News

Lusaris: Treating Depression with a New Version of an Old Psychotropic

Nov 8, 2022 | BioCentury

RA Capital Backs Another Startup Hunting for a Better Antidepressant

Nov 2, 2022 | BioPharma Dive

Lusaris Launches with $60M to Advance Psychedelic-Based Depression Therapeutic

Nov. 2, 2022 | BioSpace